Stemsynergy Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.
Trademark Applications
Trademark applications show the products and services that Stemsynergy Therapeutics is developing and marketing.
Stemsynergy Therapeutics doesn't have any recent trademark applications, indicating Stemsynergy Therapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
STEMSYNERGY THERAPEUTICS Pharmaceutical research and development services in the field of oncology and tissue regeneration; Pharmaceutical drug discovery services in the field of oncology and tissue regeneration
02/21/2019
SSTI Pharmaceutical research and development services in the field of oncology and tissue regeneration; Pharmaceutical drug discovery services in the field of oncology and tissue regeneration
02/21/2019
See all trademarks and details in the Full Report.
Market Share of Stemsynergy Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Stemsynergy Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Stemsynergy Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Stemsynergy Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.